Elevated Liver Biochemistries in Hospitalized Chinese Patients With Severe COVID-19: Systematic Review and Meta-analysis.
Alexander J KovalicGlen HuangPaul J ThuluvathSanjaya Kumar SatapathyPublished in: Hepatology (Baltimore, Md.) (2021)
Comorbidities, including coronary artery disease, cerebrovascular disease and chronic obstructive pulmonary disease, are more prevalent in hospitalized Chinese patients with severe/critical illness from COVID-19, and these patients are more likely to manifest with abnormal liver chemistries. Further prospective studies are crucial to understand the pathophysiologic mechanisms underlying the hepatic manifestations of the novel COVID-19 infection and its clinical significance.
Keyphrases
- coronavirus disease
- chronic obstructive pulmonary disease
- sars cov
- coronary artery disease
- end stage renal disease
- ejection fraction
- chronic kidney disease
- early onset
- newly diagnosed
- peritoneal dialysis
- prognostic factors
- heart failure
- patient reported outcomes
- percutaneous coronary intervention
- cardiovascular events
- cardiovascular disease
- drug induced
- coronary artery bypass grafting
- aortic stenosis
- aortic valve